Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xenon Pharmaceuticals Inc (XENE)

Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Pharmaceuticals: Q1 Earnings Snapshot

XENE : 36.81 (+1.91%)
Xenon Pharmaceuticals: Q4 Earnings Snapshot

Xenon Pharmaceuticals: Q4 Earnings Snapshot

XENE : 36.81 (+1.91%)
Cerence, Roivant Sciences fall; Xenon Pharmaceuticals, Shopify rise, Monday, 11/27/2023

Stocks that traded heavily or had substantial price changes on Monday: Cerence, Roivant Sciences fall; Xenon Pharmaceuticals, Shopify rise

CRNC : 3.09 (+3.34%)
SHOP.TO : 92.19 (+0.90%)
NEM : 44.51 (+2.44%)
XENE : 36.81 (+1.91%)
FCX : 51.52 (+1.72%)
Xenon Pharmaceuticals: Q3 Earnings Snapshot

Xenon Pharmaceuticals: Q3 Earnings Snapshot

XENE : 36.81 (+1.91%)
Xenon Pharmaceuticals: Q2 Earnings Snapshot

Xenon Pharmaceuticals: Q2 Earnings Snapshot

XENE : 36.81 (+1.91%)
Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Pharmaceuticals: Q1 Earnings Snapshot

XENE : 36.81 (+1.91%)
Xenon Pharmaceuticals: Q4 Earnings Snapshot

Xenon Pharmaceuticals: Q4 Earnings Snapshot

XENE : 36.81 (+1.91%)
Xenon Pharmaceuticals: Q3 Earnings Snapshot

Xenon Pharmaceuticals: Q3 Earnings Snapshot

XENE : 36.81 (+1.91%)
Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Xenon remains on track to initiate the XEN1101 Phase 3 program within second half of this year Cash runway extended into 2026 following successful...

XENE : 36.81 (+1.91%)
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Corporate Update

BURNABY, British Columbia, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company,...

XENE : 36.81 (+1.91%)

Barchart Exclusives

TDOC Stock Forecast 2025: Can Teladoc Recover from Its Record Lows?
Teladoc Health stock fell to record lows on Wednesday. Can the telehealth stock recover from its slump? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar